Practice
Open Access
Access site–related infections in patients receiving dialysis
John C. Lam and Fareed B. Kamar
CMAJ March 25, 2024 196 (11) E380; DOI: https://doi.org/10.1503/cmaj.231300
John C. Lam
Division of Infectious Diseases (Lam), Department of Medicine, University of California Los Angeles, Los Angeles, Calif.; Divisions of Nephrology and Transplant Medicine (Kamar), Department of Medicine, University of Calgary, Calgary, Alta.
MDFareed B. Kamar
Division of Infectious Diseases (Lam), Department of Medicine, University of California Los Angeles, Los Angeles, Calif.; Divisions of Nephrology and Transplant Medicine (Kamar), Department of Medicine, University of Calgary, Calgary, Alta.
MDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Access site–related infections in patients receiving dialysis
John C. Lam, Fareed B. Kamar
CMAJ Mar 2024, 196 (11) E380; DOI: 10.1503/cmaj.231300
Jump to section
- Article
- Infection is the leading cause of hospital admission and second most common cause of death in patients receiving dialysis
- Access site–related infections can be localized, systemic, or both
- Staphylococcus species, constituents of skin flora, are the most common bacteria implicated in infections
- Treatment of hemodialysis access site infections includes antimicrobial therapy and possible line removal or antibiotic lock therapy
- Treatment of PD-catheter infections includes antimicrobial therapy and possible catheter removal
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.